SI3150222T1 - Stabilni imunogenski sestavki antigenov staphylococcus aureus - Google Patents

Stabilni imunogenski sestavki antigenov staphylococcus aureus

Info

Publication number
SI3150222T1
SI3150222T1 SI201131825T SI201131825T SI3150222T1 SI 3150222 T1 SI3150222 T1 SI 3150222T1 SI 201131825 T SI201131825 T SI 201131825T SI 201131825 T SI201131825 T SI 201131825T SI 3150222 T1 SI3150222 T1 SI 3150222T1
Authority
SI
Slovenia
Prior art keywords
staphylococcus aureus
immunogenic compositions
aureus antigens
stable immunogenic
stable
Prior art date
Application number
SI201131825T
Other languages
English (en)
Inventor
Lakshmi Khandke
Akihisa Nonoyama
Tamara Shafer Hodge
Sandeep Nema
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of SI3150222T1 publication Critical patent/SI3150222T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
SI201131825T 2010-12-22 2011-12-21 Stabilni imunogenski sestavki antigenov staphylococcus aureus SI3150222T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061426476P 2010-12-22 2010-12-22
EP16193095.3A EP3150222B1 (en) 2010-12-22 2011-12-21 Stable immunogenic compositions of staphylococcus aureus antigens

Publications (1)

Publication Number Publication Date
SI3150222T1 true SI3150222T1 (sl) 2020-02-28

Family

ID=45444677

Family Applications (2)

Application Number Title Priority Date Filing Date
SI201131825T SI3150222T1 (sl) 2010-12-22 2011-12-21 Stabilni imunogenski sestavki antigenov staphylococcus aureus
SI201131064A SI2654784T1 (sl) 2010-12-22 2011-12-21 Stabilni imunogeni sestavki antigenov staphylococcus aureus

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI201131064A SI2654784T1 (sl) 2010-12-22 2011-12-21 Stabilni imunogeni sestavki antigenov staphylococcus aureus

Country Status (19)

Country Link
US (1) US20130259896A1 (sl)
EP (2) EP2654784B1 (sl)
JP (1) JP6097478B2 (sl)
KR (2) KR101808398B1 (sl)
CN (1) CN103826656B (sl)
AU (1) AU2011346535B2 (sl)
BR (1) BR112013016153A2 (sl)
CA (1) CA2819120C (sl)
DK (2) DK3150222T3 (sl)
ES (2) ES2769425T3 (sl)
HK (1) HK1197370A1 (sl)
HU (2) HUE047263T2 (sl)
IL (1) IL226793B (sl)
MX (1) MX350170B (sl)
PL (2) PL2654784T3 (sl)
PT (2) PT3150222T (sl)
RU (1) RU2570730C2 (sl)
SI (2) SI3150222T1 (sl)
WO (1) WO2012085872A2 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2580103C (en) 2004-09-22 2021-11-16 Glaxosmithkline Biologicals S.A. Immunogenic composition
KR20140119165A (ko) 2009-06-22 2014-10-08 와이어쓰 엘엘씨 황색포도상구균 혈청형 5 및 8 협막 다당류 접합체 면역원성 조성물 및 이의 제조 방법
US8568735B2 (en) 2009-06-22 2013-10-29 Wyeth Llc Immunogenic compositions of Staphylococcus aureus antigens
EP3626263A1 (en) * 2010-06-04 2020-03-25 Wyeth LLC Vaccine formulations
CN103561762A (zh) * 2011-03-16 2014-02-05 明尼苏达大学董事会 诱导针对葡萄球菌属中细菌的免疫应答的组合物和方法
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
MX370488B (es) * 2013-12-04 2019-12-16 Glaxosmithkline Biologicals Sa Prevencion de infecciones por staphylococcus aureus mediante vacunas de glucoproteina sintetizadas en escherichia coli.
ES2880306T3 (es) 2013-12-31 2021-11-24 Infectious Disease Res Inst Formulaciones de vacunas de un solo vial
EP3129001B1 (en) * 2014-04-10 2019-10-02 ASIT BioTech s.a. Hsp-free allergen preparation
EP3668541A4 (en) * 2017-08-16 2021-05-26 Merck Sharp & Dohme Corp. FORMULATIONS FOR PNEUMOCOCCAL CONJUGATE VACCINE
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
KR102649069B1 (ko) 2018-05-31 2024-03-19 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 안면 홍조 개선용 조성물
JP7079984B2 (ja) * 2018-07-28 2022-06-03 エクソコバイオ インコーポレイテッド エキソソームの凍結乾燥方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
AU2021207632A1 (en) * 2020-01-13 2022-07-07 Aptevo Research And Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
HU212924B (en) 1989-05-25 1996-12-30 Chiron Corp Adjuvant formulation comprising a submicron oil droplet emulsion
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
WO1997014800A1 (en) 1995-10-16 1997-04-24 Smithkline Beecham Plc Novel saliva binding protein
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
CA2310217A1 (en) 1997-11-26 1999-06-03 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
WO2000012131A1 (en) * 1998-08-31 2000-03-09 Inhibitex, Inc. Multicomponent vaccines
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
CA2411575C (en) 2000-06-08 2015-04-07 Walter Schmidt Immunostimulatory oligodeoxynucleotides
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
JP2005508143A (ja) 2001-06-07 2005-03-31 ワイス・ホールデイングス・コーポレーシヨン アジュバントとしてのコレラホロトキシンの突然変異形
EP1404368B1 (en) 2001-06-07 2009-12-09 Wyeth Holdings Corporation Mutant forms of cholera holotoxin as an adjuvant
EP2339344A1 (en) 2001-06-15 2011-06-29 Inhibitex, Inc. Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
AU2004220590B2 (en) 2003-03-07 2010-02-18 Inhibitex, Inc. Polysaccharide - Staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
CA2519511A1 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
CA2580103C (en) * 2004-09-22 2021-11-16 Glaxosmithkline Biologicals S.A. Immunogenic composition
GB0606416D0 (en) * 2006-03-30 2006-05-10 Glaxosmithkline Biolog Sa Immunogenic composition
CN103169960A (zh) * 2006-03-30 2013-06-26 葛兰素史密丝克莱恩生物有限公司 免疫原性组合物
AR060187A1 (es) * 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Composicion inmunogenica
WO2007127668A2 (en) 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
RU2541784C2 (ru) * 2006-11-07 2015-02-20 Санофи Пастер Байолоджикс Ко. Лиофилизированная композиция для индукции иммунного ответа на флавивирус, композиция и способ для ее получения
MX2010008799A (es) 2008-03-05 2010-09-07 Sanofi Pasteur Proceso para estabilizar una composicion de vacuna que contiene adyuvante.
US8568735B2 (en) * 2009-06-22 2013-10-29 Wyeth Llc Immunogenic compositions of Staphylococcus aureus antigens

Also Published As

Publication number Publication date
KR101808398B1 (ko) 2017-12-12
CN103826656B (zh) 2015-08-26
KR20150129071A (ko) 2015-11-18
PL2654784T3 (pl) 2017-08-31
EP3150222A1 (en) 2017-04-05
EP2654784B1 (en) 2016-12-07
HUE047263T2 (hu) 2020-04-28
RU2570730C2 (ru) 2015-12-10
WO2012085872A2 (en) 2012-06-28
MX350170B (es) 2017-08-28
AU2011346535A1 (en) 2013-06-13
MX2013006960A (es) 2013-07-15
DK3150222T3 (da) 2020-01-27
EP3150222B1 (en) 2019-11-27
RU2013128277A (ru) 2015-01-27
AU2011346535B2 (en) 2015-09-24
HUE033072T2 (hu) 2017-11-28
PT3150222T (pt) 2020-02-03
ES2614815T3 (es) 2017-06-02
JP6097478B2 (ja) 2017-03-15
ES2769425T3 (es) 2020-06-25
JP2012136518A (ja) 2012-07-19
BR112013016153A2 (pt) 2017-07-11
HK1197370A1 (en) 2015-01-16
KR20130114210A (ko) 2013-10-16
CA2819120C (en) 2016-07-05
PT2654784T (pt) 2017-02-13
US20130259896A1 (en) 2013-10-03
SI2654784T1 (sl) 2017-01-31
CA2819120A1 (en) 2012-06-28
PL3150222T3 (pl) 2020-05-18
DK2654784T3 (en) 2017-02-13
EP2654784A2 (en) 2013-10-30
CN103826656A (zh) 2014-05-28
IL226793B (en) 2019-02-28
WO2012085872A3 (en) 2012-08-30

Similar Documents

Publication Publication Date Title
HK1197370A1 (en) Stable immunogenic compositions of staphylococcus aureus antigens
IL217084A0 (en) Immunogenic compositions of staphylococcus aureus antigens
ZA202002470B (en) Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
IL231104A0 (en) Helper assemblies of antigens for Staphylococcus aureus
ZA201403788B (en) Stable pesticidal compositions
EP2549993A4 (en) ANTIMICROBIAL COMPOSITIONS
BR112013017664A2 (pt) composições de pó de cacau
IL238328A0 (en) Stable preparations that include peracetic acid
EP2848257A4 (en) VACCINE COMPOSITION FOR PREVENTING STAPHYLOCOCCUS AUREUS INFECTION
EP2605654A4 (en) ANTIMICROBIAL COMPOSITIONS
PL2407155T3 (pl) Formulacje inekalcytolu
EP2640418A4 (en) IMMUNOGENIC COMPOSITIONS
ZA201301908B (en) Immunogenic compositions
GB201111128D0 (en) Antimicrobial compositions
GB201013150D0 (en) Antimicrobial compositions
GB201010944D0 (en) Antimicrobial compositions
GB201003799D0 (en) Antimicrobial compositions
GB201002594D0 (en) Antimicrobial compositions
TH132076B (th) องค์ประกอบต้านจุลชีพ (antimicrobial compositions)